As 2026 approaches, one conclusion is unavoidable: nanomaterials are no longer merely a “promising” field of innovation. They are becoming an essential technological foundation. All sectors and all industries undergoing transition will require the contribution of nanoparticles—energy, healthcare, electronics, and the environment. The good news is that the nanomaterials industry has now reached a sufficient […]
On the eve of 2026, a clear conclusion emerges
Nanoparticles are attracting significant attention, both for their medical applications and their growing role in the industry. This week’s headlines highlight nanomaterials that open up new therapeutic avenues (notably in treating cardiovascular diseases and obesity), while also raising questions about illegal imports of banned products in Europe. Here is an overview of the latest developments […]
Nanoparticles & Nanomaterials: this week’s news
R-Nano declarations: time to ensure compliance With every new year come obligatory R-Nano declarations. But what are they? Nanoparticles possess innovative properties that could revolutionise the chemistry and healthcare of tomorrow. And yet, there are concerns about their use. It’s therefore crucial that the use of nanomaterials be closely monitored by public authorities to ensure […]
R-Nano Declarations
We’re delighted to share some excellent news: SON has been awarded its CIR (Crédit d’impôt recherche – French research tax credit) accreditation for the next 3 years. What this means is that all our customers will be able to benefit from the research tax credit for their pursuits in research and development until 2026. The […]
SON and the CIR